Zhenyu Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Breast Cancer Cells

Silver Nanoparticles

Top Venues

Medicinal chemistry (Shariqah (United Arab Emirates))

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenyu Li, Zhiyong Liu, Yuemao Shen, Chengwu Shen
Design and Synthesis of 6-amido-3-carboxypyridazine Derivatives as Potent T3SS Inhibitors of Salmonella Enterica Serovar Typhimurium. Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
Zhenyu Li, Lejiao Jia, Hui Tang, Yuemao Shen, Chengwu Shen
LZY3016, a novel geldanamycin derivative, inhibits tumor growth in an MDA-MB-231 xenograft model. RSC advances 13 (20) (2023)
Shuaiya Ma, Ye Tian, Jiali Peng, Chaojia Chen, Xueqi Peng, Fabao Zhao, Zhenyu Li, Mengzhen Li, Fangcheng Zhao, Xue Sheng, Runzhe Zong, Yiquan Li, Jiwei Zhang, Mingyan Yu, Qingfen Zhu, Xiaoyu Tian, Yuyang Li, Markus R Neckenig, Huiqing Liu, Peng Zhan, Xuetian Yue, Zhuanchang Wu, Lifen Gao, Xiaohong Liang, Xinyong Liu, Chunyang Li, Chunhong Ma
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. Science translational medicine 15 (722) (2023)
Zhenyu Li, Lejiao Jia, Hui Tang, Yuemao Shen, Chengwu Shen
LZY3016, a novel geldanamycin derivative, inhibits tumor growth in an MDA-MB-231 xenograft model. RSC advances 13 (20) (2023)
Zhenyu Li, Lejiao Jia, Hui Tang, Yuemao Shen, Chengwu Shen
Synthesis and biological evaluation of geldanamycin-ferulic acid conjugate as a potent Hsp90 inhibitor. RSC advances 9 (72) (2019)